Facebook
Twitter
Telegram
Report an ErrorSpruce Biosciences Financial Statements 2011-2024 | SPRB
Annual Financial Statements Spruce Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
29.3 M | 53.6 M | 104 M | 462 M | - | - | - | - | - | - | - | - | - |
Shares |
38.5 M | 23.5 M | 23.4 M | 22.3 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
0.76 | 2.28 | 4.46 | 24.3 | - | - | - | - | - | - | - | - | - |
Net Income |
-47.9 M | -46.2 M | -42.3 M | -29.5 M | -13.1 M | -9.86 M | - | - | - | - | - | - | - |
Revenue |
10.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-52 M | -47.3 M | -42.1 M | -29.4 M | -13.1 M | - | - | - | - | - | - | - | - |
Interest Expense |
483 K | 420 K | 345 K | 323 K | 65 K | - | - | - | - | - | - | - | - |
EBITDA |
-51.9 M | -47.2 M | -42 M | -29.4 M | -13.1 M | -9.97 M | - | - | - | - | - | - | - |
Operating Expenses |
62.1 M | 47.3 M | 42.1 M | 29.4 M | 13.1 M | 9.97 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.6 M | 12.1 M | 11.4 M | 5.56 M | 2.29 M | 1.57 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Spruce Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
41.1 M | 41 M | 40.7 M | 40.5 M | 31.9 M | 23.6 M | 23.6 M | 23.5 M | 23.5 M | 23.5 M | 23.4 M | 23.3 M | 23.3 M | 23.3 M | 776 K | 764 K | 764 K | 764 K | 764 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-11.6 M | - | -12.4 M | -12.8 M | -12.8 M | - | -11.4 M | -11.9 M | -11.8 M | - | -11.4 M | -11.8 M | -9.89 M | - | -9.59 M | -6.45 M | -5.17 M | - | -2.55 M | -3.24 M | -4.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
2 M | - | 3.07 M | 2.16 M | 1.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-12.6 M | - | -13.7 M | -14 M | -13.2 M | - | -11.6 M | -11.9 M | -11.7 M | - | -11.4 M | -11.7 M | -9.82 M | - | -9.56 M | -6.39 M | -5.13 M | - | -2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
97 K | - | 119 K | 127 K | 131 K | - | 110 K | 94 K | 87 K | - | 88 K | 80 K | 89 K | - | 79 K | 92 K | 74 K | - | 5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-12.6 M | - | - | - | -13.2 M | - | -11.5 M | -11.9 M | -11.7 M | - | -11.4 M | -11.7 M | -9.8 M | - | -9.53 M | -6.37 M | -5.13 M | - | -2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
14.6 M | - | 16.7 M | 16.1 M | 15.2 M | - | 11.6 M | 11.9 M | 11.7 M | - | 11.4 M | 11.7 M | 9.82 M | - | 9.56 M | 6.39 M | 5.13 M | - | 2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.32 M | - | 3.24 M | 3.01 M | 3.45 M | - | 2.77 M | 2.82 M | 3.22 M | - | 2.79 M | 2.6 M | 3.1 M | - | 1.79 M | 727 K | 523 K | - | 457 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency